Ms. Duncan is an experienced pharma financial executive and board member in the pharmaceutical industry. She served as cCFOhief financial officer and sSecretary at Intercept Pharmaceuticals and as a vVice pPresident at Lehman Brothers Inc. in its corporate finance division. Currently, she sits on the board of several six different life science companies across the women’s health and oncology fields. Ms. Duncan holds an M.B.A. from the Wharton School, University of Pennsylvania and a B.S. degree from Louisiana State University.